All Stories

  1. Renoprotection by 5-Methoxytryptophan in Kidney Disease
  2. The Role of Sirt3 in Kidney Health and Disease
  3. Beneficial Effects of Butyrate on Kidney Disease
  4. Mitigating Oxidative Stress and Inflammation: The Protective Role of β-lapachone in Kidney Disease
  5. Diabetic Kidney Disease: Contribution of Phenyl Sulfate Derived from Dietary Tyrosine upon Gut Microbiota Catabolism
  6. Rodent Models of Streptozotocin-Induced Diabetes as Suitable Paradigms for Studying Diabetic Kidney Disease
  7. Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease—Volume II
  8. Orientin Protects BV-2 Microglial Cells against Hypoxia Reoxygenation Injury through Inhibiting Oxidative Stress
  9. Editorial: Diabetes and obesity effects on lung function, volume II
  10. Roles of Dihydrolipoamide Dehydrogenase in Health and Disease
  11. Renal-Protective Roles of Lipoic Acid in Kidney Disease
  12. Long-term intermittent fasting improves neurological function by promoting angiogenesis after cerebral ischemia via growth differentiation factor 11 signaling activation
  13. The Role of Ketone Bodies in Various Animal Models of Kidney Disease
  14. The Nicotinamide/Streptozotocin Rodent Model of Type 2 Diabetes: Renal Pathophysiology and Redox Imbalance Features
  15. Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD+-Dependent Enzymes and Plant-Derived Natural Products
  16. Redox Imbalance and Mitochondrial Abnormalities in Kidney Disease
  17. Folic acid‐induced animal model of kidney disease
  18. Activation of peripheral group III metabotropic glutamate receptors suppressed formalin‐induced nociception
  19. Cadmium-Induced Kidney Injury: Oxidative Damage as a Unifying Mechanism
  20. Comment on Kobroob et al. Effectiveness of N-Acetylcysteine in the Treatment of Renal Deterioration Caused by Long-Term Exposure to Bisphenol A. Biomolecules 2021, 11, 655
  21. NADH/NAD+ Redox Imbalance and Diabetic Kidney Disease
  22. <p>Antioxidative and Hypoglycemic Effect of Ta-ermi Extracts on Streptozotocin-Induced Diabetes</p>
  23. Reductive Stress-Induced Mitochondrial Dysfunction and Cardiomyopathy
  24. Urine Sample-Derived Cerebral Organoids Suitable for Studying Neurodevelopment and Pharmacological Responses
  25. Regulation of the SIRT1 signaling pathway in NMDA-induced Excitotoxicity
  26. Neuroprotection of Cyperus esculentus L. orientin against cerebral ischemia/reperfusion induced brain injury
  27. Effects of mesencephalic astrocyte-derived neurotrophic factor on cerebral angiogenesis in a rat model of cerebral ischemia
  28. Effects of dietary 5-methoxyindole-2-carboxylic acid on brain functional recovery after ischemic stroke
  29. Vagus nerve stimulation as a promising adjunctive treatment for ischemic stroke
  30. Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases
  31. Circulating factors in young blood as potential therapeutic agents for age-related neurodegenerative and neurovascular diseases
  32. Role of pseudohypoxia in the pathogenesis of type 2 diabetes
  33. The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders
  34. Chronic Inhibition of Mitochondrial Dihydrolipoamide Dehydrogenase (DLDH) as an Approach to Managing Diabetic Oxidative Stress
  35. Humanin Attenuates NMDA-Induced Excitotoxicity by Inhibiting ROS-dependent JNK/p38 MAPK Pathway
  36. Reexploring 5-methoxyindole-2-carboxylic acid (MICA) as a potential antidiabetic agent
  37. Mitochondrial protein sulfenation during aging in the rat brain
  38. Redox imbalance stress in diabetes mellitus: Role of the polyol pathway
  39. Post-ischemic administration of 5-methoxyindole-2-carboxylic acid at the onset of reperfusion affords neuroprotection against stroke injury by preserving mitochondrial function and attenuating oxidative stress
  40. Role and Possible Mechanisms of Sirt1 in Depression
  41. Administration of 5-methoxyindole-2-carboxylic acid that potentially targets mitochondrial dihydrolipoamide dehydrogenase confers cerebral preconditioning against ischemic stroke injury
  42. Ceruloplasmin, a Potential Therapeutic Agent for Alzheimer's Disease
  43. Pancreatic mitochondrial complex I exhibits aberrant hyperactivity in diabetes
  44. Redox imbalance and mitochondrial abnormalities in the diabetic lung
  45. Non‐Gradient Blue Native Polyacrylamide Gel Electrophoresis
  46. The Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity
  47. Potential Biochemical Mechanisms of Lung Injury in Diabetes
  48. Glutaredoxins concomitant with optimal ROS activate AMPK through S-glutathionylation to improve glucose metabolism in type 2 diabetes
  49. Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
  50. Two-dimensional gel electrophoretic detection of protein carbonyls derivatized with biotin-hydrazide
  51. Comparison of antioxidant and antiproliferative activity between Kunlun Chrysanthemum flowers polysaccharides (KCCP) and fraction PII separated by column chromatography
  52. Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target
  53. Protein Modifications as Manifestations of Hyperglycemic Glucotoxicity in Diabetes and Its Complications
  54. Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity
  55. Cerebral small vessel disease and Alzheimer’s disease
  56. Role of RAGE in Alzheimer’s Disease
  57. Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic β cell glucotoxicity
  58. Activation of mTOR: a culprit of Alzheimer’s disease?
  59. Two dimensional blue native/SDS-PAGE to identify mitochondrial complex I subunits modified by 4-hydroxynonenal (HNE)
  60. Antioxidant Activity, Antitumor Effect, and Antiaging Property of Proanthocyanidins Extracted fromKunlun ChrysanthemumFlowers
  61. Roles of Pyruvate, NADH, and Mitochondrial Complex I in Redox Balance and Imbalance inβCell Function and Dysfunction
  62. Mitochondrial Dihydrolipoamide Dehydrogenase Is Upregulated in Response to Intermittent Hypoxic Preconditioning
  63. Role of insulin resistance in Alzheimer’s disease
  64. PTEN degradation after ischemic stroke: A double-edged sword
  65. Cancer-associated Isocitrate Dehydrogenase 1 (IDH1) R132H Mutation and D-2-Hydroxyglutarate Stimulate Glutamine Metabolism under Hypoxia
  66. Protein Redox Modification as a Cellular Defense Mechanism against Tissue Ischemic Injury
  67. Positive oxidative stress in aging and aging-related disease tolerance
  68. Pathogenesis of Chronic Hyperglycemia: From Reductive Stress to Oxidative Stress
  69. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
  70. Reversible inactivation of dihydrolipoamide dehydrogenase by mitochondrial hydrogen peroxide
  71. Telomere Shortening and Alzheimer’s Disease
  72. Neuroprotective Actions of Methylene Blue and Its Derivatives
  73. Roles of AMP-activated Protein Kinase in Alzheimer’s Disease
  74. Ethanol withdrawal acts as an age-specific stressor to activate cerebellar P38 kinase
  75. Chemical probes for analysis of carbonylated proteins: A review
  76. Alternative Mitochondrial Electron Transfer as a Novel Strategy for Neuroprotection
  77. Nongradient blue native gel analysis of serum proteins and in-gel detection of serum esterase activities
  78. Resolving mitochondrial protein complexes using nongradient blue native polyacrylamide gel electrophoresis
  79. Analysis of Oxidative Modification of Proteins
  80. Estrogen Receptor   as a Mitochondrial Vulnerability Factor
  81. Analysis of Oxidative Modification of Proteins
  82. Changes in dihydrolipoamide dehydrogenase expression and activity during postnatal development and aging in the rat brain
  83. Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner
  84. Human αB-Crystallin Mutation Causes Oxido-Reductive Stress and Protein Aggregation Cardiomyopathy in Mice
  85. Histochemical staining and quantification of dihydrolipoamide dehydrogenase diaphorase activity using blue native PAGE
  86. Hypoxia-inducible Factor 2  Regulates Expression of the Mitochondrial Aconitase Chaperone Protein Frataxin
  87. Pyruvate protects mitochondria from oxidative stress in human neuroblastoma SK-N-SH cells
  88. Mass spectrometry-based survey of age-associated protein carbonylation in rat brain mitochondria
  89. Mouse HSF1 Disruption Perturbs Redox State and Increases Mitochondrial Oxidative Stress in Kidney
  90. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1−/− mice
  91. Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage
  92. Analysis of Oxidative Modification of Proteins
  93. Heat shock factor 1 and heat shock proteins: Critical partners in protection against acute cell injury
  94. Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damamge to specific mitochondrial proteins
  95. Effects of aging and hyperoxia on oxidative damage to cytochrome c in the housefly, Musca domestica1
  96. Analysis of Oxidative Modification of Proteins
  97. Gel Electrophoretic Quantitation of Protein Carbonyls Derivatized with Tritiated Sodium Borohydride
  98. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging
  99. Identification of Oxidized Proteins Based on Sodium Dodecyl Sulfate–Polyacrylamide Gel Electrophoresis, Immunochemical Detection, Isoelectric Focusing, and Microsequencing
  100. Macromolecular carbonyls in human stratum corneum: a biomarker for environmental oxidant exposure?
  101. UV-Irradiation Depletes Antioxidants and Causes Oxidative Damage in a Model of Human Skin
  102. The Lipoic Acid Analogue 1,2-Diselenolane-3-pentanoic Acid Protects Human Low Density Lipoprotein against Oxidative Modification Mediated by Copper Ion
  103. Oxidative damage during aging targets mitochondrial aconitase
  104. Apolipoprotein B Carbonyl Formation Is Enhanced by Lipid Peroxidation during Copper-Mediated Oxidation of Human Low-Density Lipoproteins
  105. Efficacy of Hypochlorous Acid Scavengers in the Prevention of Protein Carbonyl Formation
  106. Antioxidant Activity of Diethyldithiocarbamate
  107. Spectrophotometric Method for Determination of Carbonyls in Oxidatively Modified Apolipoprotein B of Human Low-Density Lipoproteins
  108. Ginkgo Biloba Extract (EGb 761) Protects Human Low-Density Lipoproteins against Oxidative Modification Mediated by Copper
  109. Oxidative DNA damage and senescence of human diploid fibroblast cells.
  110. Elucidation of Antioxidant Activity of α-Lipoic Acid Toward Hydroxyl Radical
  111. Induction of Protein Oxidation in Human Low Lipoprotein by the Photosensitive Organic Hydroperoxide, N,N′-bis(2-Hydroxyperoxy-2-Methoxyethyl)-1,4,5,8-Naphthalene-Tetra-Carboxylic-Diimide
  112. Effects of oxygen radicals on the conformation of sulfhydryl groups on human polymorphonuclear leukocyte membranes
  113. Experimental studies on some aspects of toxicological effects of gas phase cigarette smoke (GPCS)